Abbvie and Genentech Join TrumpRx to Offer Discounted Medications
Abbvie and Genentech have become the latest pharmaceutical companies to join TrumpRx, a White House initiative aimed at reducing prescription drug prices. These companies will offer popular medications at significantly reduced prices on the TrumpRx platform. Abbvie will provide Humira, used for conditions like rheumatoid arthritis, at an 86% discount, while Genentech will offer Xofluza, a flu treatment, at a reduced cost. The Trump administration is working to formalize these discount deals under the 'Great Healthcare Plan,' although Congress has yet to consider the proposal. The initiative primarily benefits uninsured individuals or those whose insurance does not cover these medications. 
